Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
Mol Oncol
; 11(9): 1156-1171, 2017 09.
Article
in En
| MEDLINE
| ID: mdl-28556483
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Proto-Oncogene Proteins
/
Protein Serine-Threonine Kinases
/
Nerve Sheath Neoplasms
/
Cell Cycle Proteins
/
Drug Resistance, Neoplasm
/
Deoxycytidine
/
Protein Kinase Inhibitors
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Mol Oncol
Journal subject:
BIOLOGIA MOLECULAR
/
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
Noruega